XBP1 and metabolic dysfunction-associated steatohepatitis: Hepatic XBP1 ablation causes enhanced expression and activity of its upstream activator IRE1α, therefore we investigated the effect of hepatic IRE1α deletion in the HFS dietary model of NASH.